Neutral
Pharming Group reports first quarter 2026 financial
Pharming Group reported its first quarter 2026 financial results, with total revenues decreasing by 8% to US$72.4 million compared to Q1 2025. While R...
PHAR
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (1)
Bearish (0)
Latest PHAR News
Neutral
Bullish
Pharming Group announces presentations at CIS 2026 Annual
Pharming Group N.V. is presenting new data at the 2026 Annual Meeting of the Clinical Immunology Society, focusing on its drug leniolisib. Presentatio...
Research PHAR on:
Ad Space